Trial intelligence / Profile preview

Aerosolized Drug Deposition in Ventilated Patients

NCT02818270Completed

Sponsor
Chang Gung University
Start
Jun 2016
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of salbutamol and acetylcysteine inhalation solution in chronic obstructive pulmonary disease (COPD), sponsored by Chang Gung University. Primary endpoint: Inhaled drug dose at 20 minutes. Started Jun 2016; status: completed.

02

Drugs

salbutamolacetylcysteine inhalation solution
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT02818270.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02818270.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call